BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17075813)

  • 41. Anti-dsDNA and complement profiles in systemic lupus erythematosus.
    Swaak AJ; Groenwold J; Bronsveld W; Douma J; Feltkamp TE
    Neth J Med; 1981; 24(4):152-6. PubMed ID: 7024831
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic CD154 antibody for lupus: promise for the future?
    Kelsoe G
    J Clin Invest; 2003 Nov; 112(10):1480-2. PubMed ID: 14617748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High levels of a common anti-DNA idiotype (16/6), a genetic marker for SLE.
    Shoenfeld Y; Brill S; Weinberger A; Pinkhas J; Isenberg DA
    Acta Haematol; 1986; 76(2-3):107-9. PubMed ID: 3101346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Origin and significance of autoantibodies.
    Dighiero G; Kaushik A; Poncet P; Ge XR
    Concepts Immunopathol; 1987; 4():42-76. PubMed ID: 3297339
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic modalities in systemic lupus erythematosus.
    Tyagi NK; Lahita RG
    Saudi Med J; 2013 Sep; 34(9):887-95. PubMed ID: 24042998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-DNA antibodies in systemic lupus erythematosus: a case of mistaken identity?
    Pisetsky DS
    J Rheumatol; 1998 Feb; 25(2):195-7. PubMed ID: 9489804
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.
    Koike T; Tomioka H; Kumagai A
    Clin Exp Immunol; 1982 Nov; 50(2):298-302. PubMed ID: 7151328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M; Hiam KM; Edmond C; Assem E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction: The first Merinoff Symposium, 'Systemic Lupus: Bringing Science to the Patient'.
    Batliwalla F; Tracey KJ
    J Intern Med; 2009 Jun; 265(6):622-4. PubMed ID: 19493055
    [No Abstract]   [Full Text] [Related]  

  • 50. [Recent immunosuppressive therapy of systemic lupus erythematosus].
    Abe T
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1376-80. PubMed ID: 1702825
    [No Abstract]   [Full Text] [Related]  

  • 51. Lupus erythematosus, treatment?
    Lockshin MD
    Ann Intern Med; 1973 Jun; 78(6):969-70. PubMed ID: 4713578
    [No Abstract]   [Full Text] [Related]  

  • 52. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.
    Gordon C; Amissah-Arthur MB; Gayed M; Brown S; Bruce IN; D'Cruz D; Empson B; Griffiths B; Jayne D; Khamashta M; Lightstone L; Norton P; Norton Y; Schreiber K; Isenberg D;
    Rheumatology (Oxford); 2018 Jan; 57(1):14-18. PubMed ID: 29029296
    [No Abstract]   [Full Text] [Related]  

  • 53. Cerebral lupus erythematosus.
    Appenzeller O; Williams RC
    Ann Intern Med; 1979 Mar; 90(3):430-1. PubMed ID: 426414
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunology. New clues to systemic lupus.
    Bach JF; Koutouzov S
    Lancet; 1997 Dec 20-27; 350 Suppl 3():SIII11. PubMed ID: 9465187
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific removal of DNA antibodies in vivo by extracorporeal circulation over DNA immunobilized in collodion charcoal.
    Terman DS; Petty D; Harbeck R; Carr RI; Buffaloe G
    Clin Immunol Immunopathol; 1977 Jul; 8(1):90-6. PubMed ID: 328198
    [No Abstract]   [Full Text] [Related]  

  • 56. Systemic lupus erythematosus--disease management.
    Gourley MF
    Springer Semin Immunopathol; 1994; 16(2-3):281-94. PubMed ID: 7716709
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytokines in systemic lupus erythematosus.
    Poole BD; Niewold TB; Tsokos GC; Via CS
    J Biomed Biotechnol; 2010; 2010():735169. PubMed ID: 21603232
    [No Abstract]   [Full Text] [Related]  

  • 58. What one lipid giveth, another taketh away.
    Joyce S; Spiller BW; Van Kaer L
    Nat Immunol; 2019 Dec; 20(12):1559-1561. PubMed ID: 31636467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precision oncology giveth and precision oncology taketh away.
    Saltz LB
    Lancet Oncol; 2019 Apr; 20(4):464-466. PubMed ID: 30857958
    [No Abstract]   [Full Text] [Related]  

  • 60. [Not Available].
    Saadoun D; Desbois AC
    Rev Med Interne; 2019 Sep; 40S():S14-S19. PubMed ID: 31627799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.